Loading clinical trials...
Loading clinical trials...
The goal of this randomized, double-blind, placebo-controlled, single ascending dose clinical trial is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of IGNX001 in peanut-...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
IgGenix Australia Pty Ltd
NCT06256146 · Peanut Allergy, Milk Allergy, Cow's, and more
NCT05695261 · Allergy, Peanut, Peanut Allergy, and more
NCT03835767 · Milk and/or Peanut Allergy
NCT04222491 · Peanut Allergy
NCT04511494 · Peanut Allergy
St Vincent's Sydney
Darlinghurst, New South Wales
Monash Health, Sleep, Allergy, and Immunology
Clayton, Victoria
Royal Melbourne Hospital
Parkville, Victoria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions